18 research outputs found
A Transgenic Mouse Model of Merkel Cell Virus Small Tumor Antigen
Merkel
cell
carcinoma
(MCC),
a
primary
cutaneous
neoplasm,
originates
in
the
mechanoreceptor
Merkel
cells
in
the
basal
layer
of
the
epidermis.
Risk
factors
include
UV
exposure,
advanced
age
and
immunosuppression,
suggesting
an
infectious
etiology.
MCC
incidence
in
the
US
is
rising,
with
approximately
1500
cases
per
year.
The
non-‐enveloped,
double-‐stranded
DNA
Merkel
cell
polyomavirus
(MCV)
is
responsible
for
approximately
80%
of
MCC
cases.
The
virus
was
discovered
by
subjecting
MCC
tissue
samples
to
digital
transcriptome
subtraction,
in
which
mRNA
is
isolated,
the
human
transcripts
subtracted
in
silico
and
the
remaining
transcripts
compared
to
viral
sequences.
MCV
expresses
differentially
spliced
Large
(LT),
Small
(sT)
and
57
kT
tumor
antigens
from
the
T
antigen
early
locus,
similar
to
other
polyomaviruses
such
as
SV40.
Both
LT
and
sT
are
critical
for
transformation.
LT
is
a
helicase
responsible
for
replication
of
the
viral
genome,
however
in
integrated
viral
genomes
it
is
either
truncated
or
mutated
to
eliminate
its
replicative
functions.
sT
contributes
to
transformation
via
hyperphosphorylation
and
inhibition
of
the
cap-‐dependent
translation
inhibitor
4E-‐BP1.
The
function
of
57
kT
remains
unknown.
Knockdown
of
LT
induces
necroptosis
of
MCV-‐
positive
MCC
cells,
whereas
sT
expression
in
rodent
Rat-‐1
cells
is
transformative.
v
Being
that
sT
is
the
transformative
agent
in
rodent
cells,
it
would
be
of
interest
to
develop
a
mouse
model
expressing
sT
in
a
tissue-‐specific
manner
to
determine
whether
tumor
formation
occurs.
Indeed,
several
mouse
models
of
SV40
T
antigen
have
been
developed
over
the
past
decades,
each
resulting
in
tissue-‐specific
tumor
formation.
We
developed
a
MCV
sT
transgenic
mouse
model,
in
which
a
lox-‐stop-‐lox
sT
is
expressed
via
an
ER-‐inducible
Cre
gene
under
the
control
of
the
ubiquitin
promoter.
Upon
tamoxifen-‐
induced
MCV
sT
expression,
ER-‐Cre-‐positive
mice
demonstrate
severe
weight
loss,
ruffled
fur
and
a
hunched
posture,
necessitating
euthanasia.
Western
blotting
reveals
sT
expression
in
several
tissues,
whereas
TUNEL
staining
shows
significant
cell
death.
While
we
were
unable
to
observe
transformation,
we
believe
this
drastic
phenotype
demonstrates
the
validity
of
our
MCV
sT
transgenic
mouse
model
and
warrants
further
investigation
into
the
mechanism
of
death
Requirement for a Uroplakin 3a-like protein in the development of zebrafish pronephric tubule epithelial cell function, morphogenesis, and polarity
Uroplakin (UP)3a is critical for urinary tract development and function; however, its role in these processes is unknown. We examined the function of the UP3a-like protein Upk3l, which was expressed at the apical surfaces of the epithelial cells that line the pronephric tubules (PTs) of the zebrafish pronephros. Embryos treated with upk3l-targeted morpholinos showed decreased pronephros function, which was attributed to defects in PT epithelial cell morphogenesis and polarization including: loss of an apical brush border and associated phospho-ERM proteins, apical redistribution of the basolateral Na+/K+-ATPase, and altered or diminished expression of the apical polarity complex proteins Prkcz (atypical protein kinase C zeta) and Pard3 (Par3). Upk3l missing its C-terminal cytoplasmic domain or containing mutations in conserved tyrosine or proline residues did not rescue, or only partially rescued the effects of Upk3l depletion. Our studies indicate that Upk3l promotes epithelial polarization and morphogenesis, likely by forming or stimulating interactions with cytoplasmic signaling or polarity proteins, and that defects in this process may underlie the pathology observed in UP3a knockout mice or patients with renal abnormalities that result from altered UP3a expression. © 2012 Mitra et al
The CT of Upk3l is critical for its function.
<p>(A) Clustal W alignment of the TM and CT region of hUP3a, xUP3a and Upk3l. The amino acids that comprise the TM and CT domain are highlighted, and conserved functional motifs and residues are underlined or shaded, respectively. (B) Phenotypes of embryos injected with CNT-MO, <i>upk3l</i>-MO alone, or <i>upk3l</i>-MO co-injected with mCherry mRNA and mRNAs encoding MO-resistant versions of <i>upk3l</i>ΔCT, <i>upk3l</i>P<sub>258</sub>L, <i>upk3l</i>Y<sub>251</sub>F, or <i>upk3l</i>Y<sub>251</sub>D. Microinjection of MO-resistant mRNA alone at the same doses did not produce detectable phenotypic abnormalities. (C) Morphological phenotypes associated with embryos injected with 5 ng CNT-MO (<i>n</i> = 100), 3 ng of <i>upk3l</i>-MO (<i>n</i> = 100), or 3 ng of <i>upk3l</i>-MO and 100 pg of <i>upk3l</i>, <i>upk3l</i>ΔCT, <i>upk3l</i>P<sub>258</sub>L, <i>upk3l</i>Y<sub>251</sub>F, or <i>upk3l</i>Y<sub>251</sub>D mRNA (n≥50). (D) Localization of FLAG-tagged Upk3l, Upk3lΔCT, Upk3lP<sub>258</sub>L, Upk3lY<sub>251</sub>F, or Upk3lY<sub>251</sub>D in MDCK cells co-stained for actin and nuclei. Upk3lY<sub>251</sub>F and Upk3lY<sub>251</sub>D showed a predominantly intracellular localization and their low levels of expression necessitated an 1.5-fold increase in photomultiplier voltage above that used for the other samples.</p
Pronephric clearance, heart rate, and pericardial area in control and morphant embryos.
<p>(A) Clearance of 70 kDa-TRITC dextran injected into the common cardinal vein of 54-hpf control (top panel) or morphant (bottom panel) embryos. The fluorescence intensity of the sampled area (circled) was measured in each embryo 0, 5, and 24 h following dextran injection. (B) The heart rate, pericardial area, and the dextran retention was recorded for each embryo and the values relative to t = 0 (post dextran injection) were calculated. Data are reported as mean ± SEM (n = 25). (C) Uptake of 500 kDa or 10 kDa FITC-dextran in control or morphant PT epithelial cells. Tubule lumens are marked by asterisks, while internalized dextran is indicated by arrows. Note the incomplete ring of actin in morphant PT cells.</p
p53 ablation is critical for MCV sT transformation of MEF cells.
<p>(A) MCV sT induces soft agar colony formation in the absence of p53 in MEF cells. MEF cells isolated form <i>Ubc</i><sup><i>CreERT2</i></sup><i>; ROSA</i><sup><i>sT</i></sup>, <i>ROSA</i><sup><i>sT</i></sup>, <i>Ubc</i><sup><i>CreERT2</i></sup><i>; p53</i><sup><i>flox/flox</i></sup> and two <i>Ubc</i><sup><i>CreERT2</i></sup><i>; ROSA</i><sup><i>sT</i></sup><i>; p53</i><sup><i>flox/flox</i></sup> embryos from littermate were treated with 500nM 4OHTMX over 7 days, and cells were subjected to soft agar colony formation assay. Asterisks(*) indicate statistical significance <i>p<0</i>.<i>05</i>. (B) Soft agar colonies induced by p53 ablation. p53 ablation alone did not lead to colony formation. (C) Expression of MCV sT in MEFs from <i>Ubc</i><sup><i>CreERT2</i></sup><i>; ROSA</i><sup><i>sT</i></sup><i>; p53</i><sup><i>flox/flox</i></sup>.</p
MCV sT transgenic mice develop tumors in a p53 null setting.
<p>(A) p53 ablation does not rescue mice from MCV sT-induced lethality. Kaplan-Meier curve of low dose (0.02 mg/g) TMX injected <i>Ubc</i><sup><i>CreERT2</i></sup><i>; ROSA</i><sup><i>sT</i></sup><i>; p53</i><sup><i>flox/flox</i></sup> mice (Solid blue line, n = 26) and <i>Ubc</i><sup><i>CreERT2</i></sup><i>; p53</i><sup><i>flox/flox</i></sup> mice (dotted blue line, n = 10). Pink lines indicate the survival of <i>Ubc</i><sup><i>CreERT2</i></sup><i>; ROSA</i><sup><i>sT</i></sup><i>(solid line)</i> and <i>Ubc</i><sup><i>CreERT2</i></sup> (dotted line) mice with wild type p53 as shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0142329#pone.0142329.g001" target="_blank">Fig 1B</a> for comparison with p53 knockout background (blue lines). (B) MCV sT expression produces tumors <i>in vivo</i> in <i>p53</i> null setting. 80% (4/5) of mice that survived over 60 days after TMX injection develop grossly visible tumor in the spleen and liver. Representative spleen and liver tissues with tumor nodules from p53.7F are shown with corresponding normal tissues from a C57BL/6 control mouse. (C) Immunoblotting of MCV sT protein expression in liver and spleen tissues from mouse p53.7F) with macroscopic tumors. Spleen, muscle and ear tissues consistently maintained sT expression over 60 days after TMX injection. sT expression was detectable in liver tissues by immunoblotting only from liver with visible nodules (mouse p53.7F). MCV sT protein was detected using CM8E6 antibody, and Hsp/Hsc70 expression was used as a loading control. (D) The top panel shows anaplastic neoplasia in the spleen and liver. A range of proliferative changes was observed in the kidney, where distal tubular epithelia are most severely affected, but glomeruli (black arrowhead), proximal tubular epithelia (*), and interstitial tissues are relatively spared of proliferative changes. The middle panel shows a representative immunohistochemical staining of sT protein expression in liver tumor, spleen tumor and kidney tissues from <i>Ubc</i><sup><i>CreERT2</i></sup><i>; ROSA</i><sup><i>sT</i></sup><i>; p53</i><sup><i>flox/flox</i></sup> mice. Tissue samples were immunostained with MCV sT (CM5E1) antibody. (E) The top panel shows a sT-induced liver tumor with immunoreactivity to α-smooth muscle actin (ASMA) and bottom panel shows K14 positivity in scattered tumor cells.</p